# Corcept Therapeutics (CORT) — Overview

CORT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/cort

## Price

Last close $113.37 on Oct 15, 2026. 52-week range $32.15 – $123.57.

## Company profile

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $830.8M |
| Revenue (quarter) | $256.1M |
| Revenue growth (year over year) | 31.74% |
| Gross profit (trailing twelve months) | $816.7M |
| Gross margin | 98.30% |
| Net income (trailing twelve months) | $55.2M |
| Net income (quarter) | $43.0M |
| Net income growth (year over year) | 22.30% |
| Net margin | 6.64% |
| Return on equity | 8.09% |
| EPS (trailing twelve months) | $0.53 |
| Book value per share | $6.54 |
| P/E (trailing twelve months) | 225.8 |
| Price to book | 17.4 |
| Debt to assets | 20.58% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Corcept Therapeutics (CORT) profitable?

Yes. Corcept Therapeutics earned $55.2M in net income over the trailing twelve months, a net margin of 6.64%.

### How much revenue does Corcept Therapeutics (CORT) make?

Corcept Therapeutics generated $830.8M in revenue over the trailing twelve months, up 31.74% year over year.

### What is CORT's P/E ratio?

Corcept Therapeutics trades at 225.8 times trailing twelve-month earnings, on an EPS of $0.53.

### How do I buy stock in Corcept Therapeutics (CORT)?

CORT trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

## Similar Stocks

- [ANVS](https://www.lighthorse.io/tickers/anvs) — Annovis Bio, Inc. Common Stock

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).